Batavia Biosciences provides high quality biopharmaceuticals for proof-of-concept studies and clinical studies, as well as aid product development for all major classes of biopharmaceuticals. The company focuses on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development (mammalian, microbial & insect cell platforms), purification development, product characterization, and clinical manufacturing. Batavia Biosciences aims to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicines from discovery to the clinic. Its technologies helps (pharma) companies complete their preclinical phases in product development at higher speed, reduced cost, and with higher success rate.
Select investors Bill & Melinda Gates Foundation
Last update: May 13, 2018
Disclaimer: We can not guarantee that the information on this page is 100% correct. more